ICU Medical, Inc.

NasdaqGS:ICUI Lagerbericht

Marktkapitalisierung: US$4.1b

ICU Medical Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

ICU Medical wird ein jährliches Gewinn- und Umsatzwachstum von 72.6% bzw. 1.1% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 72.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 6.8% betragen.

Wichtige Informationen

72.6%

Wachstumsrate der Gewinne

72.2%

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum17.1%
Wachstumsrate der Einnahmen1.1%
Zukünftige Eigenkapitalrendite6.8%
Analystenabdeckung

Good

Zuletzt aktualisiert14 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Lifting Their Price Targets

Nov 15
ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Lifting Their Price Targets

Recent updates

ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Lifting Their Price Targets

Nov 15
ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Lifting Their Price Targets

A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Oct 01
A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Bounce 30% But Its Business Still Trails The Industry

Aug 18
ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Bounce 30% But Its Business Still Trails The Industry

ICU Medical (NASDAQ:ICUI) Seems To Use Debt Quite Sensibly

Aug 07
ICU Medical (NASDAQ:ICUI) Seems To Use Debt Quite Sensibly

ICU Medical - Stabilization Is In Sight, But The Road Back Is Difficult

Jun 27

ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price

Jun 23
ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price

Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package

May 09
Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package

Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S

Apr 26
Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Mar 31
ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?

Jan 31
Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

Jan 04
ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively

Oct 28
These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively

Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?

Oct 07
Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Jul 19
ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Jun 22
Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Here's Why ICU Medical (NASDAQ:ICUI) Can Afford Some Debt

Apr 03
Here's Why ICU Medical (NASDAQ:ICUI) Can Afford Some Debt

Estimating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Feb 27
Estimating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Dec 07
ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Sep 07
ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

ICU Medical Hit Hard As Smiths Medical Needs Significant TLC

Aug 20

ICU Medical Non-GAAP EPS of $1.37 misses by $0.29, revenue of $561M misses by $3.1M

Aug 08

FDA labels ICU Medical unit's April recall of syringe infusion pumps as most serious

Jul 20

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Jun 08
ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

ICU Medical: There Is Still Upside Here As Management Goes Big To Drive Value

Mar 25

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:ICUI - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20262,463931882976
12/31/20252,398-51682637
12/31/20242,326-1121131347
9/30/20242,340-111160255N/A
6/30/20242,304-71157254N/A
3/31/20242,257-5975171N/A
12/31/20232,259-3073166N/A
9/30/20232,249-28-1373N/A
6/30/20232,294-48-4440N/A
3/31/20232,306-46-110-20N/A
12/31/20222,280-74-161-62N/A
9/30/20222,043-39-7822N/A
6/30/20221,7815-199N/A
3/31/20221,54141124215N/A
12/31/20211,316103186268N/A
9/30/20211,296109175263N/A
6/30/20211,279103168260N/A
3/31/20211,26094146235N/A
12/31/20201,27187122223N/A
9/30/20201,2668198193N/A
6/30/20201,2558373168N/A
3/31/20201,2648760162N/A
12/31/20191,266101-4102N/A
9/30/20191,291733103N/A
6/30/20191,311471104N/A
3/31/20191,3595557160N/A
12/31/20181,4002959160N/A
9/30/20181,4308690195N/A
6/30/20181,44686N/A242N/A
3/31/20181,41718N/A210N/A
12/31/20171,29369N/A154N/A
9/30/20171,01828N/A91N/A
6/30/201777247N/A19N/A
3/31/2017537101N/A-4N/A
12/31/201637963N/A90N/A
9/30/201637259N/A84N/A
6/30/201636156N/A77N/A
3/31/201634853N/A68N/A
12/31/201534045N/A64N/A
9/30/201532947N/A61N/A
6/30/201532137N/A61N/A
3/31/201531629N/A61N/A
12/31/201430726N/A66N/A
9/30/201430632N/A72N/A
6/30/201431137N/A69N/A
3/31/201431138N/A68N/A
12/31/201331240N/A66N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: ICUI wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.6%).

Ertrag vs. Markt: ICUI wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: ICUI wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: ICUIDie Einnahmen des Unternehmens (1.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.9% pro Jahr).

Hohe Wachstumseinnahmen: ICUIDie Einnahmen des Unternehmens (1.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: ICUIDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (6.8%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y